With the spread of the coronavirus, many individuals are concerned about access to their medication supply. At this time, MannKind does not anticipate that the supply of its inhalable insulin Afrezza® (insulin human) Inhalation Powder will be affected by the coronavirus.
We will continue to closely monitor our supply chain for potential impact to the supply of Afrezza. MannKind sources critical raw materials from suppliers in the United States and Europe and we remain in close communication with key suppliers to assure a reliable supply of insulin.
Our US manufacturing facility is fully operational and we are taking a number of steps to prevent any impact to our supplies. Afrezza is still readily available in U.S. pharmacies, and if needed, pharmacies can order additional supplies from wholesalers with expected delivery within 1-2 days. As the global situation evolves, we will continue to take the necessary steps to safeguard the reliable supply of Afrezza. For more information about Afrezza, visit www.afrezza.com.
(insulin human) inhalation powder
What is the most important information I should know about AFREZZA?
AFREZZA can cause serious side effects, including: Sudden lung problems (bronchospasms). Do not use AFREZZA if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD). Before starting AFREZZA, your healthcare provider will give you a breathing test to check how your lungs are working.
What is AFREZZA?
Who should not use AFREZZA?
AFREZZA if you:
What should I tell my healthcare provider before using AFREZZA?
Before using AFREZZA, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the counter medicines, vitamins or herbal supplements. Before you start using AFREZZA, talk to your healthcare provider about low blood sugar and how to manage it.
How should I use AFREZZA?
Your dose of AFREZZA may need to change because of:
What should I avoid while using AFREZZA?
While using AFREZZA do not:
What are the possible side effects of AFREZZA?
AFREZZA may cause serious side effects that can lead to death, including:
See “What is the most important information I should know about AFREZZA?”
Get emergency medical help if you have:
The most common side effects of AFREZZA include:
General information about the safe and effective use of AFREZZA.
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use AFREZZA for a condition for which it was not prescribed. Do not give AFREZZA to other people, even if they have the same symptoms that you have. It may harm them. This Medication Guide summarizes the most important information about AFREZZA. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about AFREZZA that is written for health professionals.
What are the ingredients in AFREZZA?
Active ingredient: human insulin
Inactive ingredients: fumaryl diketopiperazine, polysorbate 80
AFREZZA® is a registered trademark owned by MannKind Corporation
MannKind Corporation, Danbury, CT 06810
For more information, go to www.AFREZZA.com or call MannKind Corp. 1-877-323-8505
This Medication Guide has been approved by the U.S. Food and Drug Administration. Revised 10/2018
Please see all Important Safety Information for AFREZZA (insulin human) Inhalation Powder and Full Prescribing Information, including BOXED WARNING, Medication Guide and Instructions for Use.
AFREZZA and the Afrezza logo are registered marks, all owned by MannKind Corporation.
© MannKind Corporation 2020. US-AFR-0882
This communication is intended for U.S. residents only.